Maxillary Sinus Floor Augmentation in Diabetic Patients

Launched by UNIVERSITY OF COPENHAGEN · Sep 2, 2020

Keywords

ClinConnect Summary

This clinical trial is investigating how effective two different methods are for placing dental implants in diabetic patients who are missing teeth in the back part of their upper jaw. The study will compare the use of a bone graft taken from the patient's own body to a new treatment called advanced platelet-rich fibrin (APRF), which is derived from the patient's blood. The goal is to see if patients who receive APRF experience similar success with their implants as those who receive the bone graft, without the need for additional surgery to harvest bone.

To participate, individuals must be at least 20 years old, have insulin-dependent diabetes, and have missing teeth in the back of their upper jaw, with enough remaining bone to support an implant. Participants will undergo various evaluations before and after the procedure to assess how well the implants are doing, including checking the stability of the bone around the implant and overall oral health. This study aims to make the process of getting dental implants safer and simpler for diabetic patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥20 years.
• • Insulin-dependent diabetes with missing posterior maxillary tooth/teeth.
• • Residual bone height of the maxillary alveolar process between 4 and 7 mm.
• • Width of the alveolar process ≥6.5 mm.
• • Presence of mandibular occluding teeth.
• • Plasma glucose levels below 7.8 mmol/l or 140 mg/dl.
• Exclusion Criteria:
• • Contraindications to implant therapy.
• • Full mouth plaque score \>25%.
• • Progressive periodontitis.
• • Acute infection in the area intended for implant placement.
• • Parafunction, bruxism, or clenching.
• • Psychiatric problems or unrealistic expectations.
• • Smoking. Previous smoker will not be excluded.
• • Pregnancy